---
figid: PMC9272595__bsr-42-bsr20212051-g8
figtitle: Oncogenic receptor tyrosine kinase pathway with its downstream signaling
  pathways and small molecule inhibitors targeting different proteins of the network
organisms:
- Mus musculus
- Rattus norvegicus
- Astragalus membranaceus
- Rat sarcoma virus
- Cowpea mosaic virus
- Khaya anthotheca
- Homo sapiens
- Danio rerio
- gut metagenome
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC9272595
filename: bsr-42-bsr20212051-g8.jpg
figlink: /pmc/articles/PMC9272595/figure/F8/
number: F8
caption: Receptor tyrosine kinase (RTK) plays a significant role in cellular proliferation.
  MAPK and PI3K-AKT-mTOR pathways are two key downstream pathways of RTK. Targeting
  these pathways has remained a successful approach to cause the antitumor effect.
  Small molecule inhibitors have been widely used for targeting different components
  of such pathways. Several small molecule inhibitors targeting different proteins
  of RTK signaling pathways are depicted in this diagram.
papertitle: Emerging concepts in designing next-generation multifunctional nanomedicine
  for cancer treatment.
reftext: Kasturee Chakraborty, et al. Biosci Rep. 2022 Jul 29;42(7):BSR20212051.
year: '2022'
doi: 10.1042/BSR20212051
journal_title: Bioscience Reports
journal_nlm_ta: Biosci Rep
publisher_name: Portland Press Ltd.
keywords: Cancer | Combination therapy | Immuno therapy | Nanomedicine | peptide
automl_pathway: 0.9561713
figid_alias: PMC9272595__F8
figtype: Figure
redirect_from: /figures/PMC9272595__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9272595__bsr-42-bsr20212051-g8.html
  '@type': Dataset
  description: Receptor tyrosine kinase (RTK) plays a significant role in cellular
    proliferation. MAPK and PI3K-AKT-mTOR pathways are two key downstream pathways
    of RTK. Targeting these pathways has remained a successful approach to cause the
    antitumor effect. Small molecule inhibitors have been widely used for targeting
    different components of such pathways. Several small molecule inhibitors targeting
    different proteins of RTK signaling pathways are depicted in this diagram.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Grb2
  - Akt1
  - Pik3r1
  - Serpina1d
  - Mtor
  - Egfr
  - Pdgfrb
  - Axl
  - Ros1
  - KRAS
  - HRAS
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTG1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LBR
  - SERPINA4
  - MTOR
  - EGFR
  - PDGFRB
  - PDGFRA
  - KDR
  - FLT1
  - FLT4
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - AXL
  - IGF1R
  - ROS1
  - Pck1
  - Ephb1
  - Pik3cg
  - rab1ab
  - pak2a
  - itpka
  - kita
  - ngfra
  - grb2b
  - mtor
  - egfra
  - axl
  - foxa2
  - ros1
  - Ras64B
  - Ras85D
  - MKP-4
  - p38b
  - rl
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - Tie
  - InR
  - drk
  - Sos
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Mi-2
  - Tor
  - Pvr
  - btl
  - htl
---
